Business Description
Kamada Ltd
SIC : 2836
ISIN : IL0010941198
Total Employee Number:
462Compare
Compare
Traded in other countries / regions
KMDA.IsraelKMDA.USA IPO Date
2005-08-31Description
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.94 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.27 | |||||
Interest Coverage | 26.78 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.61 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.9 | |||||
3-Year EBITDA Growth Rate | 41.5 | |||||
3-Year FCF Growth Rate | -21 | |||||
3-Year Book Growth Rate | 5.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 23.51 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.63 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.15 | |||||
9-Day RSI | 70.7 | |||||
14-Day RSI | 67.59 | |||||
3-1 Month Momentum % | 6.27 | |||||
6-1 Month Momentum % | -15.44 | |||||
12-1 Month Momentum % | -1.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.06 | |||||
Quick Ratio | 2.29 | |||||
Cash Ratio | 1.43 | |||||
Days Inventory | 273.1 | |||||
Days Sales Outstanding | 61.68 | |||||
Days Payable | 79.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.96 | |||||
Dividend Payout Ratio | 0.66 | |||||
Forward Dividend Yield % | 1.96 | |||||
5-Year Yield-on-Cost % | 2.02 | |||||
3-Year Average Share Buyback Ratio | -8.8 | |||||
Shareholder Yield % | 1.97 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 40.82 | |||||
Operating Margin % | 14.51 | |||||
Net Margin % | 11.6 | |||||
EBITDA Margin % | 22.43 | |||||
FCF Margin % | 13.85 | |||||
OCF Margin % | 18.93 | |||||
ROE % | 8.41 | |||||
ROA % | 5.89 | |||||
ROIC % | 8.58 | |||||
3-Year ROIIC % | 76.59 | |||||
ROC (Joel Greenblatt) % | 23.17 | |||||
ROCE % | 8.45 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 22.85 | |||||
Forward PE Ratio | 15.5 | |||||
PE Ratio without NRI | 23.42 | |||||
Shiller PE Ratio | 26.95 | |||||
Price-to-Owner-Earnings | 18.52 | |||||
PEG Ratio | 1.08 | |||||
PS Ratio | 2.64 | |||||
PB Ratio | 1.86 | |||||
Price-to-Tangible-Book | 3.45 | |||||
Price-to-Free-Cash-Flow | 19.17 | |||||
Price-to-Operating-Cash-Flow | 14.12 | |||||
EV-to-EBIT | 15.98 | |||||
EV-to-EBITDA | 10.29 | |||||
EV-to-Revenue | 2.31 | |||||
EV-to-Forward-Revenue | 1.97 | |||||
EV-to-FCF | 15.53 | |||||
Price-to-GF-Value | 1.01 | |||||
Price-to-Projected-FCF | 1.4 | |||||
Price-to-Median-PS-Value | 1.1 | |||||
Price-to-Graham-Number | 1.9 | |||||
| Price-to-Net-Current-Asset-Value | 5.83 | |||||
Earnings Yield (Greenblatt) % | 6.25 | |||||
FCF Yield % | 5.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kamada Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚Ş) | 607.006 | ||
| EPS (TTM) (â‚Ş) | 1.195 | ||
| Beta | 0.8896 | ||
| 3-Year Sharpe Ratio | 0.12 | ||
| 3-Year Sortino Ratio | 0.2 | ||
| Volatility % | 18.6 | ||
| 14-Day RSI | 67.59 | ||
| 14-Day ATR (â‚Ş) | 0.728208 | ||
| 20-Day SMA (â‚Ş) | 25.0275 | ||
| 12-1 Month Momentum % | -1.9 | ||
| 52-Week Range (â‚Ş) | 19.56 - 28.9 | ||
| Shares Outstanding (Mil) | 57.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kamada Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kamada Ltd Stock Events
| Event | Date | Price (â‚Ş) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-03-11 08:30 | In 173 days | ||
| Annual report for 2026 | 2027-03-11 | In 172 days | ||
| Fourth quarter earnings results for 2026 | 2027-03-11 | In 172 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-10 08:30 | In 52 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 51 days | ||
| H.C. Wainwright 28th Annual Global Investment Conference | 2026-09-15 14:30 | 25.05 (+2.66%) | ||
| USD 0.170000 Cash Dividend | 2026-08-27 | 25.33 (-0.59%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-12 08:30 | 21.30 (+0.95%) | ||
| Second quarter earnings results for 2026 | 2026-08-12 | 21.30 (+0.95%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 08:30 | 24.50 (-2.00%) |
Show
Entries
Kamada Ltd Frequently Asked Questions
What is Kamada Ltd(XTAE:KMDA)'s stock price today?
The current price of XTAE:KMDA is â‚Ş26.33. The 52 week high of XTAE:KMDA is â‚Ş28.90 and 52 week low is â‚Ş19.56.
When is next earnings date of Kamada Ltd(XTAE:KMDA)?
The next earnings date of Kamada Ltd(XTAE:KMDA) is 2026-11-10 Est..
Does Kamada Ltd(XTAE:KMDA) pay dividends? If so, how much?
The Dividend Yield %  of Kamada Ltd(XTAE:KMDA) is 1.96% (As of Today), Highest Dividend Payout Ratio of Kamada Ltd(XTAE:KMDA) was 0.66. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Kamada Ltd(XTAE:KMDA) is 1.96%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers